# ORIC (Oric Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> Oric Pharmaceuticals, Inc. reported $366.9M in total assets and a net loss of $155.8M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/ORIC
- Markdown: https://convexityos.com/fundamentals/ORIC.md
- SEC CIK: 0001796280
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:31 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001796280&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$171.0M | Operating profit |
| Net Income | FY 2025 | -$155.8M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$1.44 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$129.2M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $261.4M | Total debt: $3.35M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $109.8M | $114.1M | $85.17M | $61.68M | $56.86M | $35.92M | $22.84M | $19.03M |
| Total Operating Expenses | $143.0M | $142.9M | $110.8M | $91.77M | $78.87M | $74.19M | $28.57M | $22.37M |
| **Operating Income** | -$143.0M | -$142.9M | -$110.8M | -$91.77M | -$78.87M | -$74.19M | -$28.57M | -$22.37M |
| **EBITDA** | -$141.8M | -$141.8M | -$109.7M | -$90.80M | -$77.97M | -$73.22M | -$27.54M | -$21.47M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$129.5M | -$127.8M | -$100.7M | -$89.12M | -$78.72M | -$73.70M | -$26.88M | -$21.36M |
| Basic EPS | -$1.47 | -$1.83 | -$1.96 | -$2.25 | -$2.07 | -$3.36 | -$14.15 | -$49.28 |
| **Diluted EPS** | -$1.47 | -$1.83 | -$1.96 | -$2.25 | -$2.07 | -$3.36 | -$14.15 | -$49.28 |
| Basic Shares Outstanding | 87.8M | 69.7M | 51.5M | 39.7M | 38.0M | 21.9M | 1.9M | 433.5K |
| Diluted Shares Outstanding | 87.8M | 69.7M | 51.5M | 39.7M | 38.0M | 21.9M | 1.9M | 433.5K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $43.36M | $36.30M | $31.44M | $25.86M | $28.77M | $30.55M | $24.64M | $31.97M |
| Total Operating Expenses | $51.55M | $45.30M | $39.62M | $34.55M | $36.67M | $39.06M | $32.72M | $39.57M |
| **Operating Income** | -$51.55M | -$45.30M | -$39.62M | -$34.55M | -$36.67M | -$39.06M | -$32.72M | -$39.57M |
| **EBITDA** | -$51.27M | -$45.03M | -$39.35M | -$34.23M | -$36.38M | -$38.75M | -$32.42M | -$39.27M |
| **Net Income** | -$48.08M | -$41.49M | -$35.77M | -$30.50M | -$32.59M | -$36.35M | -$30.02M | -$36.31M |
| Basic EPS | -$0.44 | -$0.38 | -$0.34 | -- | -$0.33 | -$0.47 | -$0.42 | -- |
| **Diluted EPS** | -$0.44 | -$0.38 | -$0.34 | -- | -$0.33 | -$0.47 | -$0.42 | -- |
| Basic Shares Outstanding | 108.2M | 108.0M | 105.5M | -- | 99.0M | 78.1M | 71.0M | -- |
| Diluted Shares Outstanding | 108.2M | 108.0M | 105.5M | -- | 99.0M | 78.1M | 71.0M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $45.67M | $59.41M | $23.38M | $66.84M | $226.0M | $78.45M | $89.16M |
| Short-Term Investments | $235.8M | $196.6M | $184.8M | $139.4M | $10.97M | $215.2M | -- |
| **Cash & Short-Term Investments** | $281.5M | $256.0M | $208.2M | $206.3M | $237.0M | $293.6M | $89.16M |
| **Total Current Assets** | $288.5M | $262.2M | $212.6M | $210.5M | $240.5M | $296.7M | $90.00M |
| Property, Plant & Equipment, Net | $2.42M | $2.92M | $2.86M | $3.25M | $2.41M | $1.98M | $2.24M |
| Long-Term Investments | $110.8M | $0 | $26.85M | $21.95M | $43.39M | $0 | -- |
| Other Non-Current Assets | $7.25M | $8.97M | $9.70M | $11.52M | $12.32M | $319K | $1.85M |
| **Total Non-Current Assets** | $120.4M | $11.89M | $39.41M | $36.72M | $58.12M | $2.30M | $4.09M |
| **Total Assets** | $408.9M | $274.1M | $252.0M | $247.2M | $298.6M | $299.0M | $94.09M |
| Accounts Payable | $3.82M | $1.55M | $944K | $1.32M | $1.89M | $757K | $152K |
| **Total Current Liabilities** | $20.42M | $24.85M | $20.46M | $15.39M | $15.15M | $9.00M | $5.35M |
| Long-Term Debt | -- | -- | -- | -- | $10.50M | -- | -- |
| Other Non-Current Liabilities | $4.11M | $6.17M | $7.46M | $9.44M | $10.52M | $219K | -- |
| **Total Non-Current Liabilities** | $4.11M | $6.17M | $7.46M | $9.44M | $10.52M | $219K | $765K |
| **Total Liabilities** | $24.53M | $31.02M | $27.92M | $24.83M | $25.67M | $9.22M | $6.12M |
| **Total Debt (incl. Leases)** | $7.44M | $9.36M | $10.21M | $12.10M | $22.94M | -- | -- |
| Common Stock | $11K | $7.0K | $6.0K | $5.0K | $4.0K | $4.0K | -- |
| Retained Earnings | -$692.2M | -$562.8M | -$434.9M | -$334.2M | -$245.1M | -$166.4M | -$92.69M |
| Accumulated Other Comp. Income | $786K | $379K | $258K | -$1.29M | -$103K | -$31K | -- |
| **Total Stockholders' Equity** | $384.4M | $243.1M | $224.1M | $222.4M | $273.0M | $289.8M | -$90.08M |
| Total Equity | $384.4M | $243.1M | $224.1M | $222.4M | $273.0M | $289.8M | -$90.08M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $33.85M | $37.48M | $56.40M | $45.67M | $49.67M | $75.86M | $49.33M | $59.41M |
| Short-Term Investments | $227.5M | $227.3M | $225.5M | $235.8M | $237.5M | $206.6M | $154.4M | $196.6M |
| **Cash & Short-Term Investments** | $261.4M | $264.8M | $281.9M | $281.5M | $287.1M | $282.5M | $203.7M | $256.0M |
| **Total Current Assets** | $274.8M | $273.7M | $290.2M | $288.5M | $295.6M | $291.1M | $211.4M | $262.2M |
| Property, Plant & Equipment, Net | $2.08M | $2.24M | $2.15M | $2.42M | $2.56M | $2.76M | $3.02M | $2.92M |
| Long-Term Investments | $83.99M | $122.8M | $137.8M | $110.8M | $125.9M | $45.22M | $20.04M | $0 |
| Other Non-Current Assets | $6.06M | $5.95M | $6.60M | $7.25M | $7.13M | $7.75M | $8.37M | $8.97M |
| **Total Non-Current Assets** | $92.14M | $131.0M | $146.5M | $120.4M | $135.6M | $55.73M | $31.43M | $11.89M |
| **Total Assets** | $366.9M | $404.7M | $436.8M | $408.9M | $431.2M | $346.9M | $242.9M | $274.1M |
| Accounts Payable | $2.15M | $3.87M | $2.90M | $3.82M | $2.90M | $3.13M | $5.16M | $1.55M |
| **Total Current Liabilities** | $24.78M | $20.76M | $17.77M | $20.42M | $20.18M | $18.05M | $17.62M | $24.85M |
| Other Non-Current Liabilities | $2.61M | $2.67M | $3.43M | $4.11M | $4.09M | $4.81M | $5.50M | $6.17M |
| **Total Non-Current Liabilities** | $2.61M | $2.67M | $3.43M | $4.11M | $4.09M | $4.81M | $5.50M | $6.17M |
| **Total Liabilities** | $27.38M | $23.43M | $21.20M | $24.53M | $24.27M | $22.86M | $23.12M | $31.02M |
| **Total Debt (incl. Leases)** | $3.35M | $3.33M | $3.30M | $7.44M | $3.30M | $3.27M | $3.21M | $9.36M |
| Common Stock | $11K | $11K | $11K | $11K | $11K | $9.0K | $7.0K | $7.0K |
| Retained Earnings | -$817.6M | -$769.5M | -$728.0M | -$692.2M | -$661.7M | -$629.1M | -$592.8M | -$562.8M |
| Accumulated Other Comp. Income | -$1.69M | -$1.02M | -$290K | $786K | $615K | $187K | $209K | $379K |
| **Total Stockholders' Equity** | $339.5M | $381.3M | $415.6M | $384.4M | $406.9M | $324.0M | $219.7M | $243.1M |
| Total Equity | $339.5M | $381.3M | $415.6M | $384.4M | $406.9M | $324.0M | $219.7M | $243.1M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$129.5M | -$127.8M | -$100.7M | -$89.12M | -$78.72M | -$73.70M | -$26.88M | -$21.36M |
| Depreciation & Amortization | $1.22M | $1.11M | $1.03M | $966K | $897K | $970K | $1.03M | $903K |
| Stock-Based Compensation | $25.04M | $20.21M | $15.23M | $14.46M | $12.85M | $5.28M | $1.09M | $469K |
| **Operating Cash Flow** | -$111.0M | -$112.7M | -$85.69M | -$75.14M | -$59.54M | -$45.27M | -$23.53M | -$20.68M |
| Capital Expenditure | -$712K | -$1.19M | -$849K | -$2.08M | -$939K | -$667K | -$768K | -$525K |
| **Free Cash Flow** | -$111.7M | -$113.8M | -$86.54M | -$77.22M | -$60.48M | -$45.94M | -$24.30M | -$21.21M |
| Purchases of Investments | -$399.8M | -$251.9M | -$239.2M | -$238.1M | -$69.63M | -$225.5M | -- | -- |
| **Investing Cash Flow** | -$148.0M | $22.14M | -$43.40M | -$109.2M | $158.4M | -$216.0M | -$768K | -$508K |
| Common Stock Issued | $244.4M | $125.0M | $85.00M | $25.00M | $50.00M | $271.3M | -- | -- |
| **Financing Cash Flow** | $245.3M | $126.5M | $85.66M | $25.23M | $49.13M | $250.5M | $70.82M | $38.01M |
| **Net Change in Cash** | -$13.74M | $36.02M | -$43.43M | -$159.2M | $148.0M | -$10.71M | $46.52M | $16.82M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$48.08M | -$41.49M | -$35.77M | -$30.50M | -$32.59M | -$36.35M | -$30.02M | -$36.31M |
| Depreciation & Amortization | $279K | $264K | $270K | $320K | $288K | $310K | $302K | $304K |
| Stock-Based Compensation | $6.19M | $7.09M | $6.90M | $6.28M | $5.63M | $6.57M | $6.55M | $5.20M |
| **Operating Cash Flow** | -$41.99M | -$31.61M | -$32.44M | -$22.48M | -$25.11M | -$30.84M | -$32.53M | -$28.05M |
| Capital Expenditure | -$107K | -$356K | -$2.0K | -$227K | -$35K | -$63K | -$387K | -$219K |
| **Free Cash Flow** | -$42.09M | -$31.96M | -$32.44M | -$22.71M | -$25.15M | -$30.91M | -$32.92M | -$28.27M |
| Purchases of Investments | -$17.35M | -$47.78M | -$77.97M | -$45.29M | -$165.5M | -$124.4M | -$64.66M | -$34.63M |
| **Investing Cash Flow** | $37.54M | $11.86M | -$17.98M | $16.98M | -$110.5M | -$76.93M | $22.45M | $42.66M |
| Common Stock Issued | $0 | $0 | $60.88M | $0 | $110.4M | $133.9M | $0 | $0 |
| **Financing Cash Flow** | $806K | $828K | $61.14M | $1.50M | $109.5M | $134.3M | $11K | $575K |
| **Net Change in Cash** | -$3.64M | -$18.91M | $10.73M | -$4.00M | -$26.20M | $26.53M | -$10.07M | $15.18M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -33.7% | -52.6% | -44.9% | -40.1% | -28.8% | -25.4% | -- | -- |
| Return on Assets (ROA) | -31.7% | -46.6% | -40.0% | -36.1% | -26.4% | -24.7% | -28.6% | -- |
| Current Ratio | 14.13x | 10.56x | 10.39x | 13.68x | 15.87x | 32.96x | 16.81x | -- |
| Quick Ratio | 13.79x | 10.30x | 10.18x | 13.40x | 15.64x | 32.61x | 16.65x | -- |
| Debt to Equity | 0.02x | 0.04x | 0.05x | 0.05x | 0.08x | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -45.9% | -36.8% | -32.5% | -33.7% | -33.2% | -42.4% | -60.5% | -52.6% |
| Return on Assets (ROA) | -42.5% | -34.7% | -31.0% | -31.7% | -31.4% | -39.6% | -54.7% | -46.6% |
| Current Ratio | 11.09x | 13.19x | 16.33x | 14.13x | 14.65x | 16.13x | 12.00x | 10.56x |
| Quick Ratio | 10.55x | 12.76x | 15.86x | 13.79x | 14.23x | 15.65x | 11.56x | 10.30x |
| Debt to Equity | 0.01x | 0.01x | 0.01x | 0.02x | 0.01x | 0.01x | 0.01x | 0.04x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
